Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BSQKZ | FITB |
|---|---|---|
| Price | $76.79 | $50.80 |
| Change today | ▲ 0.00% | ▼ 0.14% |
| Market cap | $46.14B | $46.07B |
| Return, 3 months | +2.4% | -11.6% |
| Return, year to date | -2.9% | +11.2% |
| Return, 1 year | -1.2% | +19.8% |
| P/E (TTM) | 137.1 | 17.1 |
| P/B | 52.3 | 1.4 |
| P/E percentile vs own 5y | – | 93rd |
| Dividend yield | – | 3.15% |
| Revenue growth (YoY, latest qtr) | – | +44.4% |
| Net profit growth (YoY) | – | +27.5% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 20.9% |
| Return on equity | – | 8.6% |
| Analyst target vs. price | – | +25.1% |
| Analyst buy share | – | 85% |
| RSI (14) | 41 | 36 |
| 30-day volatility | 32.5% | 19.7% |
| Max drawdown, 1 year | -33.7% | -21.2% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
